% | $
Quotes you view appear here for quick access.

Aegerion Pharmaceuticals, Inc. (AEGR) Message Board

  • ramki54 ramki54 Oct 17, 2012 10:42 AM Flag

    Updates from Panel Review - AF's Comments

    adam feuerstein: AEGR knows that it has to hew close to high risk HoFH patients if it wants to get lomi approved. Any suggestion of population creep makes the risk-benefit argument more challenging.

    adam feuerstein: so far, so good for AEGR

    Comment From Take Take : ]
    AGER defending its product very well... Nice still lots of dicussions to go...
    Wednesday October 17, 2012 10:16 Take

    10:16 adam feuerstein: agreed

    adam feuerstein: AEGR's presentation was very well done.

    adam feuerstein: AEGR and its docs stress that hoFH definition is made on clinical parameters not on mutation of the LDL receptors. IF thats true, patients numbers will be higher.

2.19+0.06(+2.82%)Oct 20 4:00 PMEDT